International Isotopes Inc

OTC:INIS

International Isotopes, Inc. engages in the manufacture of nuclear medicine calibration and reference standards cobalt tele therapy sources, as well as radioisotopes and radiochemical for medical research and clinical devices. The company is headquartered in Idaho Falls, Idaho and currently employs 30 full-time employees. Its segments include Nuclear Medicine Standards, which consists of the manufacture of sources and standards associated with Single Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET) imaging, patient positioning, and calibration or operational testing of dose-measuring equipment for the nuclear pharmacy industry; Cobalt Products, which includes management of a cobalt irradiation contract, fabrication of cobalt capsules for teletherapy or irradiation devices, and recycling of expended cobalt sources; Radiochemical Products, which includes production and distribution of Iodine-131 generic drug product and isotopically pure radiochemicals; Fluorine Products, which is involved in the production of small-scale qualification samples of high purity fluoride gas, and Radiological Services, which consists of gemstone processing and source disposal services.